Poxel Appoints Industry Leader Dr. David E. Moller as Chief Scientific Officer
Park Square has placed David Moller, MD, as Chief Scientific Officer at Poxel SA.
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic...…